Skip to main content
Signal8

Hamm John M.

SEC insider (Form 3/4/5 filer). CIK 0001870439. VP Chief Financial Officer at CUMBERLAND PHARMACEUTICALS INC (CPIX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 18, 2026. Located in NASHVILLE, TN.

Companies Hamm John M. has filed insider reports for

  • CUMBERLAND PHARMACEUTICALS INC (CPIX): Officer, VP Chief Financial Officer
Hamm John M. profile photo

Hamm John M.

CIK: 0001870439

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CUMBERLAND PHARMACEUTICALS INC logo
CPIX

CUMBERLAND PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 18, 2026
    Award

    Options (right to buy)

    Direct
    3K shares at avg. $2.80-
  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 17, 2025
    Award

    Options (right to buy)

    Direct
    2.8K shares at avg. $5.17-
  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 16, 2025
    Tax Payment
    Direct
    5.9K shares at avg. $5.46$32K

1-3 of 3